Join us Thursday at 1 pm EDT as Salmaan kanji presents #COVID19RX webinar titled "Drug Shortages During the COVID-19 Pandemic: Conservation Strategies and Therapeutic Alternatives." Register bit.ly/2MLtNew The Ottawa Hospital Université d'Ottawa | University of Ottawa

Cross-Country Conversations - Webinar #5: Intensive Care youtu.be/yFsiRDUb1II via YouTube. #COVID19Ontario #COVID19 #covid19Canada

Per CDC, COVID vaccines looking impressively safe. Through Dec 22, after nearly 1 million doses, only 307 ED visits, almost all of them for minor symptoms. #1: dizziness

We’re taking a page from the book of @ottawahealth and using the trusty Twitter thread to share an update on the current COVID-19 situation in our hospital, and hospitals throughout the community. Please take a minute to read this... [1/9]

Our latest SR-MA, published in Annals of Surgery, suggests that among adult trauma patients, LMWH is superior to UFH for DVT and VTE prevention and may additionally reduce pulmonary embolism and mortality.

Great talk on pharmacologic confounders to BD/DNC at #NCS2021. Be conservative.

Another amazing PharmD talk at #NCS2021 Neurocritical Care Society. This time Salmaan kanji speaks to the classic question: “have I waited long enough off sedatives to declare brain death?”

Salmaan kanji discusses pharmacologic confounders in #braindeath Neurocritical Care Society: 👉🏽no need to wait for complete elimination, just therapeutic range or less 👉🏽T1/2 altered in ICU 👉🏽prolonged infusions affect Vd, Cl 👉🏽be conservative with estimates #NCS2021 #NCSPharmacy

ApARTogether Virtual Showcase iicanada.org/news/community…

🆕 overview of systemic reviews describing incidence proportion and severity of adverse effects associated with immune checkpoint inhibitors. Early recognition of these AEs = better patient outcomes ⬇️ link.springer.com/article/10.100…

ICI therapy has improved the outlook of so many cancers but you have to understand the risks! Lots of adverse events to be aware of. Greater awareness=earlier recognition=better outcomes. Debanjali Pierre Thabet

ICI therapy has revolutionized cancer therapy but you must know the risks. Congrats Sydney Morin, ⁦Debanjali⁩ ⁦Pierre Thabet⁩ ⁦@kyla_agtarap⁩. Check out our newest overview of systematic reviews. link.springer.com/article/10.100…

Interested in methods when conducting an "overview of reviews"? Look no further than our paper about managing primary study overlap across systematic reviews ⬇️

Vitamin C. A great case of waiting for evidence before exposing patients to interventions of unclear benefit / harm #LOVITtrial #CCR22

Too many systematic reviews on the same topic? How do you choose? Our team led by Carole Lunny is working on developing a tool using AI to help YOU choose the one worth reading but we need to hear from you! Please take our 10 minute survey. tinyurl.com/yckzpmv2

Please share - Our WISEST survey has reached 500 respondents! The survey asks how if and how you choose amongst competing #systematicreview s on the same topic. Any field of research is applicable! Link to the survey is here: ubc.ca1.qualtrics.com/jfe/form/SV_39… Art by savagechickens.bsky.social

The four horsemen of #Grant #writing

Combination CFTR modulators have revolutionized #cysticfibrosis care, but there remain concerns of drug-drug interactions. Out now in Journal of CF our review examining these interactions with a focus on Trikafta/Kaftrio 👇👇 authors.elsevier.com/c/1gR7U5aosmEg…

It is with great pleasure that we announce the appointment of Dr. Christine Landry as the Program Director of Université d'Ottawa | University of Ottawa brand-new PharmD program! We wish her all the best in her new role ! Read the article here: bit.ly/3RCBrZC Christine Landry, PharmD (she/her) Daniel Figeys uOttawa | Faculté de médecine, Faculty of Medicine